Literature DB >> 15714519

Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene.

Steven F Dobrowolski1, Jason T McKinney, Cristina Amat di San Filippo, Keow Giak Sim, Bridget Wilcken, Nicola Longo.   

Abstract

Primary carnitine deficiency is an autosomal recessive disorder of fatty acid oxidation resulting from defective carnitine transport. This disease is caused by mutations in the OCTN2 carnitine transporter encoded by the SLC22A5 gene. Here we validate dye-binding/high-resolution thermal denaturation as a screening procedure to identify novel mutations in this gene. This procedure is based on the amplification of DNA by PCR in capillaries with the dsDNA binding dye LCGreen I. The PCR reaction is then analyzed in the same capillary by high-resolution thermal denaturation. Samples with abnormal melting profiles are sequenced. This technique correctly identified all known patients who were compound heterozygotes for different mutations in the carnitine transporter gene and about 30% of homozygous patients. The remaining 70% of homozygous patients were identified by a second amplification, in which the patient's DNA was mixed with the DNA of a normal control. This screening system correctly identified eight novel mutations and both abnormal alleles in six new families with primary carnitine deficiency. The causative role of the missense mutations identified (c.3G>T/p.M1I, c.695C>T/p.T232M, and c.1403 C>G/p.T468R) was confirmed by expression in Chinese hamster ovary (CHO) cells. These results expand the mutational spectrum in primary carnitine deficiency and indicate dye-binding/high-resolution thermal denaturation as an ideal system to screen for mutations in diseases with no prevalent molecular alteration. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714519     DOI: 10.1002/humu.20137

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

1.  High-resolution melting analysis, a simple and effective method for reliable mutation scanning and frequency studies in the ACADVL gene.

Authors:  Rikke Katrine Jentoft Olsen; Steven F Dobrowolski; Margrethe Kjeldsen; David Hougaard; Henrik Simonsen; Niels Gregersen; Brage Storstein Andresen
Journal:  J Inherit Metab Dis       Date:  2010-05-18       Impact factor: 4.982

Review 2.  High resolution melting applications for clinical laboratory medicine.

Authors:  Maria Erali; Karl V Voelkerding; Carl T Wittwer
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

3.  High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.

Authors:  Aouatef Riahi; Maher Kharrat; Imen Lariani; Habiba Chaabouni-Bouhamed
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

4.  Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency.

Authors:  M Kilic; R K Ozgül; T Coşkun; D Yücel; M Karaca; H S Sivri; A Tokatli; M Sahin; T Karagöz; A Dursun
Journal:  JIMD Rep       Date:  2011-09-22

5.  Functional and molecular studies in primary carnitine deficiency.

Authors:  Marta Frigeni; Bijina Balakrishnan; Xue Yin; Fernanda R O Calderon; Rong Mao; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2017-09-14       Impact factor: 4.878

6.  Genotype-phenotype correlation in primary carnitine deficiency.

Authors:  Emily C Rose; Cristina Amat di San Filippo; Uzochi C Ndukwe Erlingsson; Orly Ardon; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2011-10-11       Impact factor: 4.878

7.  Classification of DNA sequences based on thermal melting profiles.

Authors:  Edward Reese; Vishwanathan V Krishnan
Journal:  Bioinformation       Date:  2010-04-30

8.  High-resolution melting curve analysis of genomic and whole-genome amplified DNA.

Authors:  Michael H Cho; Dawn Ciulla; Barbara J Klanderman; Benjamin A Raby; Edwin K Silverman
Journal:  Clin Chem       Date:  2008-12       Impact factor: 8.327

9.  Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  Marie-Pierre Audrezet; Aurélia Dabricot; Cédric Le Marechal; Claude Ferec
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

10.  Cardiomyopathy and carnitine deficiency.

Authors:  Cristina Amat di San Filippo; Matthew R G Taylor; Luisa Mestroni; Lorenzo D Botto; Nicola Longo
Journal:  Mol Genet Metab       Date:  2008-03-11       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.